微创医学

目的探讨腹腔镜左半肝切除治疗肝胆管结石合并肝硬化的安全性和可行性。方法将46例肝胆管结石患者按有无合并肝硬化分组，其中无肝硬化组38例, 合并肝硬化组8例，均采用腹腔镜左半肝切除治疗肝胆管结石，比较两组疗效。结果合并肝硬化组和无肝硬化组的患者术中输血率分别为62.5%（5/8）和18.4%（7/38），术后并发症发生率分别为75.0%（6/8）与26.3%（10/38），术后平均住院时间分别为(12.38±3.29)d与(9.08±2.93)d，两组比较，差异均有统计学意义(P＜0.05)；两组手术时间、术中出血量、中转开腹率、胃肠道功能恢复时间方面比较，差异均无统计学意义(P＞0.05)。结论腹腔镜左半肝切除治疗左肝胆管结石合并肝硬化安全可行。

ObjectiveTo evaluate the safety and feasibility of laparoscopic left hepatectomy in the treatment of hepatolithiasis combined with cirrhosis. MethodsA total of 46 patients with hepatolithiasis were divided into two groups according to the situation of cirrhosis, 38 cases in cirrhosis group and 8 cases in liver cirrhosis group. All patients were treated with laparoscopic left hepatectomy. The curative effects of were compared between the two groups. ResultsThe rate of intraoperative blood transfusion was 62.5% (5/8) and (7/38), the incidence of postoperative complications was 75% (6/8) and (10/38), The average length of hospital stay was (12.38±3.29)d and (9.08±2.93)d, respectively; the difference between the two groups was statistically significant (P＜0.05). There was no significant difference between the two groups in operative time, intraoperative blood loss, conversion to laparotomy, and recovery time of gastrointestinal function (P＞0.05). ConclusionLaparoscopic left hepatectomy is safe and feasible in the treatment of hepatolithiasis combined with left hepatolithiasis.

无